Biolase stock forecast.
The recent spike has left investors curious about Biolase's stock price forecast. Will it come down soon or keep rising and exit the penny stock zone? BOIL's stock outlook leans bullish right now ...
A. The latest price target for Biolase ( NASDAQ: BIOL) was reported by Lake Street on Wednesday, May 31, 2023. The analyst firm set a price target for 0.40 expecting BIOL to fall to within 12 ...Jul 26, 2023 · Shortly following the special meeting, the Board of Directors exercised such discretion to effect a 1-for-100 reverse stock split that will become effective at 11:59 p.m. Eastern Time on July 27, 2023, and the Company's common stock will begin trading on a split-adjusted basis at the opening of the market on July 28, 2023. Detailed statistics for BIOLASE, Inc. (BIOL) stock, including valuation metrics, financial numbers, share information and more. Detailed statistics for BIOLASE, Inc. (BIOL) stock, including valuation metrics, financial numbers, share information and more. ... Analyst Forecast. The average price target for BIOLASE is $113.33, which is …Oct 26, 2021 · For BIOLASE stock forecast for 2031, 12 predictions are offered for each month of 2031 with average BIOLASE stock forecast of $1.91, a high forecast of $3.64, and a low forecast of $0.72. The average BIOLASE stock forecast 2031 represents a 66.26% increase from the last price of $1.14999997615814. For BIOLASE stock forecast for 2033 (10 year ... Forecast for July 2025. It is predicted that the price of one BIOLASE share in will be in the range of $0.95 to $1.11. The width of this range will be $0.17 (15.15%). The average price is $1.05, which is $0.07 higher than the average price of the previous month.
Dec 1, 2023 · Get a real-time BIOLASE, Inc. (BIOL) stock price quote with breaking news, financials, statistics, charts and more. ... The 12-month stock price forecast is $113.33 ...
Dec 1, 2023 · Full Company Report for BIOL. View Biolase, Inc BIOL investment & stock information. Get the latest Biolase, Inc BIOL detailed stock quotes, stock data, Real-Time ECN, charts, stats and more.
Oct 26, 2023 · Analyzing the anticipated performance of BIOLASE, the ceiling value that the stock is expected to reach in 2025 stands at a promising $2.56.Indicating a bullish trend, an upside potential of 49.75% signals profitable prospects, with an average monthly return of 1.91%, beckoning investors to consider amplifying their portfolios. Based on short-term price targets offered by three analysts, the average price target for Biolase comes to $15.67. The forecasts range from a low of $3.00 to a high of $40.00. The average price ...15.17R USD +13.93 +1123.12%. The 3 analysts offering 1 year price forecasts for Biolase, Inc. have a max estimate of 40.00 and a min estimate of 2.50. BIOLASE, Inc. Provides Revenue Forecast for the Third Quarter Ending September 30, 2022 and Full Year of 2022 Aug 12 BIOLASE, Inc. to Report Q2, 2022 Results on Aug 11, 202228 mar 2023 ... ... outlook," "potential," "plan," "seek," and similar expressions and ... stock-based and other non-cash compensation, allowance for doubtful ...
21 sept 2023 ... Shares of Biolase saw signs of life in the stock market today. The ... Instead of waiting for its share price to climb, it has conducted a ...
May 18, 2023 · In late afternoon trading, the technology-focused benchmark was up 1.3% to 13,823, its best level since April 2022, boosted by strong performances from Nvidia and Alphabet during the session. With ...
Proceeds from the sale of common stock and pre-funded warrants. 8,503 — Proceeds from the exercise of common stock warrants. 14 — Net cash and cash equivalents provided by financing activities ...The Theriva Biologics, Inc. stock price gained 5.10% on the last trading day (Friday, 17th Nov 2023), rising from $0.390 to $0.410. During the last trading day the stock fluctuated 15.38% from a day low at $0.390 to a day high of $0.450. The price has been going up and down for this period, and there has been a -6.43% loss for the last 2 weeks.Nov 30, 2023 · Analyst Recommendations on BIOLASE, Inc. Biolase Files Registration Statement for Unit Offering at Target Price of $60 a Unit. Sep. 12. MT. Lake Street Adjusts Price Target on Biolase to $0.40 From $1.50, Maintains Buy Rating. May. 31. MT. Lake Street Assumes Biolase at Buy With $1.50 Price Target. Jan. 20. It trades at 35 cents but the three firms with coverage believe it could be worth $3.83 on average. So, 2022 could be a great year to possess CWBR stock. Yet, despite the positives, Cohbar is ...Jul 26, 2023 · BIOLASE Logo (PRNewsfoto/BIOLASE, Inc.) The 1-for-100 reverse stock split will reduce the number of outstanding shares of Company common stock from approximately 104 million shares to ... Jul 26, 2023 · Shortly following the special meeting, the Board of Directors exercised such discretion to effect a 1-for-100 reverse stock split that will become effective at 11:59 p.m. Eastern Time on July 27, 2023, and the Company's common stock will begin trading on a split-adjusted basis at the opening of the market on July 28, 2023. 21 sept 2023 ... Shares of Biolase saw signs of life in the stock market today. The ... Instead of waiting for its share price to climb, it has conducted a ...
Biolase -20%. TELA Bio -18%. Adaptive Biotechnologies -14%. S&P 500 Health Care ... Goldman Sachs channels Taylor Swift for its 2024 stock market forecast Today, 4:48 PM 3 Comments.It's typically categorized as a valuation metric and is most often quoted as Cash Flow per Share and as a Price to Cash flow ratio. In this case, it's the cash flow growth that's being looked at ...Full Company Report for BIOL. View Biolase, Inc BIOL investment & stock information. Get the latest Biolase, Inc BIOL detailed stock quotes, stock data, Real-Time ECN, charts, stats and more.See the latest Biolase Inc stock price (BIOL:XNAS), related news, valuation, dividends and more to help you make your investing decisions.BIOLASE is a company that develops and sells laser systems for dental procedures. The stock has a consensus rating of …
Biolase stock price target cut to $11 from $14 at Ascendiant Capital Mar. 29, 2023 at 6:10 a.m. ET by Tomi Kilgore Biolase started at speculative buy with $2 stock price target at …BIOLASE, Inc. (NASDAQ:NASDAQ:BIOL) Q2 2023 Earnings Conference Call August 10, 2023 4:30 PM ETCompany ParticipantsTodd Kehrli - EVC GroupJohn Beaver -...
Biolase announces reverse stock split SA News Fri, Apr. 29, 2022. Biolase GAAP EPS of -$0.03, revenue of $12.4M ... provides forecast SA News Thu, May 13, 2021 1 Comment. Biolase EPS misses by $0. ...BIOLASE Stock Forecast is based on your current time horizon. Investors can use this forecasting interface to forecast BIOLASE INC historical stock prices and determine the direction of BIOLASE INC's future trends based on various well-known forecasting models. However, solely looking at the historical price movement is usually misleading.The 12-month stock price forecast is $113.33, which is an increase of 9,594.61% from the latest price. Price Target ( 9,594.61% upside) Analyst Consensus: …Evelo Biosciences Inc. $0.40. EVLO 1.25% ; Vivos Therapeutics Inc. $19.90. VVOS 18.78% ; Femasys Inc. $0.93. FEMY 2.33% ; Histogen Inc. $0.33. HSTO 2.19% ; BIOLASE ...Biolase Stock Earnings Reports . NASDAQ Stock Exchange > Healthcare > Medical Devices Open Broker Account $1.22 -0.0200 (-1.61%) At Close: Nov 22, 2023 Chart & Forecast Earnings Dividends Insider Trading Signals Historical Prices Predictions News Profile. BIOL Upcoming Earnings (Q4 2023) Earnings Date: Mar 26, 2024With the interplay of data, predictions, and real-time performance, BIOLASE's stock emerges not just as an investment opportunity but as a narrative unfolding in the grand theatre of the financial markets. Each high, low, surge, and dip is a chapter, and every investor, a reader and co-author of this evolving tale.
According to Biolase 's latest financial reports and stock price the company's current number of shares outstanding is 1,179,000. At the end of 2023 the ...
Track Biolase Inc (BIOL) Stock Price, Quote, latest community messages, chart, news and other stock related information. Share your ideas and get valuable insights from the community of like minded traders and investors
Nov 8, 2023 · On November 9, Biolase will be releasing earnings Q3. Analysts expect Biolase will report losses per share of $1.775. Go here to watch Biolase stock price in real-time ahead of earnings. Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools. Identify stocks that meet your criteria using seven unique stock screeners.If you want to keep up to date on the stock market you have a device in your pocket that makes that possible. Your phone can track everything finance-related and help keep you up to date on the world markets.Net loss attributable to common stockholders for the quarter ended September 30, 2023 was $4.6 million, or $3.89 per share, compared to a net loss of $8.4 million, or $110.36 per share (as ...We use our expertise to forecast stock prices. [email protected]; Market Opinions. Any opinions, news, research, analyses, prices, or other information offered by AIStockFinder is provided as general market commentary, and does not constitute investment advice. AIStockFinder will not accept liability for any loss or …WebBiolase Stock Earnings Reports . NASDAQ Stock Exchange > Healthcare > Medical Devices Open Broker Account $1.22 -0.0200 (-1.61%) At Close: Nov 22, 2023 Chart & Forecast Earnings Dividends Insider Trading Signals Historical Prices Predictions News Profile. BIOL Upcoming Earnings (Q4 2023) Earnings Date: Mar 26, 2024Shortly following the annual meeting, the Board of Directors exercised such discretion to effect a 1-for-25 reverse stock split that will become effective at 11:59 p.m. Eastern Time on April 28, 2022, and the Company's common stock will begin trading on a split-adjusted basis at the opening of the market on April 29, 2022.BIOLASE Stock Forecast and Price Target. The average price target for BIOLASE's stock set by recognized analysts recently is $21.50, which would result in a potential upside of approximately 1753.45% if it reached this mark. The estimation is based on a high estimate of $40.00 and a low estimate of $2.50.
BIOLASE (BIOL) Stock Forecast & Price Target $1.10 -0.05 (-4.35%) (As of 11/29/2023 ET) Compare Today's Range $1.10 $1.20 50-Day Range $1.10 $1.89 52-Week Range $1.07 $99.50 Volume 88,335 shs Average Volume 156,585 shs Market Capitalization $2.53 million P/E Ratio N/A Dividend Yield N/A Price Target $77.00As the old saying goes, “Forewarned is forearmed.” This sentiment holds true when it comes to weather forecasting as well. One of the primary advantages of a 30-day extended weather forecast is the ability to plan ahead with confidence.Biolase, Inc. (BIOL) stock forecast and price target. Find the latest Biolase, Inc. BIOL analyst stock forecast, price target, and recommendation trends with in-depth analysis from research reports. Instagram:https://instagram. biotech fda calendarshort term health insurance floridaohio fha mortgagecomposer trading platform Nov 30, 2023 · BIOLASE stock has a strong buy rating from 3 analysts, who predict an increase of 6,566.47% to $113.33 in the next 12 months. The average price target is $100, with a range of $40 to $200. The stock has a low revenue growth rate and a high EPS loss in the past year. 9 nov 2023 ... ... Forecast · 7 Day Forecast · Weather Radar · Watches and Warnings · School ... $. 483. $. 562. Deemed dividend on preferred stock. $. —. $. 217. janoneameritrade short selling Biolase Simple Moving Average . Analysis of Biolase Simple Moving Average, A two period moving average forecast for Biolase is based on an daily price series in which the stock price on a given d... invest in rentberry 13 Apr 2018. Dental laser company 'exploring strategic alternatives' as CFO takes over on interim basis. Biolase stock price: past 12 months.Sell candidate since Nov 06, 2023 Loss -8.41% PDF. The SoFi stock price fell by -0.580% on the last day (Friday, 24th Nov 2023) from $6.90 to $6.86. During the last trading day the stock fluctuated 2.35% from a day low at $6.79 to a day high of $6.95. The price has risen in 6 of the last 10 days and is up by 0.15% over the past 2 weeks.